Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Tvardi Therapeutics, Inc.”

6 pharma patents match "Tvardi Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Tvardi Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Tvardi Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12053444

    Therapeutic compounds, formulations, and uses thereof

    Tvardi Therapeutics, Inc. · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  2. US 12043640

    Prodrugs of STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  3. US 11826315

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  4. US 11547683

    Therapeutic compounds, formulations, and uses thereof

    Tvardi Therapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  5. US 11077077

    Therapeutic compounds, formulations, and uses thereof

    Tvardi Therapeutics, Inc. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted
  6. US 11026905

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted